Delivery Order SPE2DB25D3001-SPE2DB25FQUSH

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $4,512.51 and a performance period through June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $8,617.67 and a period of performance through June 6, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,102.07 and runs through February 10, 2025. It is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in healthcare settings. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.87 firm fixed-price delivery order is for the provision of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical applications. The contract has an ultimate completion date of March 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,009.94, is for the delivery of EUFLEXXA 1% 20 MG/2 ML syringes. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through April 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 IDC with the...
This is a $6,615.03 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through February 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $6,980.96 and a period of performance through May 2, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,030.20 and an ultimate completion date of January 14, 2025. The contract provides for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various healthcare applications. This contract award is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,122.42 firm fixed-price contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The contract has an ultimate completion date of April 10, 2025 and is not set aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medication used for joint pain. The delivery order has a ceiling value of $37,411.63 and a period of performance through May 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
  • SPE2DB25D3001
    Indefinite Delivery Contract
  • SPE2DB25D3001-SPE2DB25FQUSH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,566.49, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through June 12, 2025. The contract is a Firm Fixed Price (FFP) delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/14/25, 12:58 AM